Tóth M, Rácz K, Novák K, Kiss R, Mohari K, Fehér J, Gláz E
Orv Hetil. 1989 May 21;130(21):1111-3.
The authors report on a successful medical treatment of a 36-year-old woman who had hypothyroidism and pituitary adenoma. Primary hypothyroidism was evidenced by decreased serum thyroxine (23 nmol/l; 1,77 micrograms/dl) and increased plasma thyroid-stimulating hormone (TSH) levels (108 mU/l). Pituitary mass with suprasellar expansion (1 cm in diameter) was proven by computed tomography (CT). The patient had been treated conventionally with 1-thyroxine and this medication was continued during a 1-year follow-up. Not only did she become symptom-free but control CT scanning revealed a large reduction of tumor size and the disappearance of suprasellar expansion.
作者报告了一例对一名患有甲状腺功能减退症和垂体腺瘤的36岁女性的成功医学治疗案例。血清甲状腺素降低(23 nmol/L;1.77 μg/dl)和血浆促甲状腺激素(TSH)水平升高(108 mU/L)证实存在原发性甲状腺功能减退症。计算机断层扫描(CT)证实存在垂体肿块并向鞍上扩展(直径1厘米)。该患者一直采用左甲状腺素进行常规治疗,在为期1年的随访期间继续使用这种药物。她不仅症状消失,而且对照CT扫描显示肿瘤大小大幅缩小,鞍上扩展消失。